Macquarie Group LTD Vanda Pharmaceuticals Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$6.87 - $10.96 $11 Million - $17.6 Million	-1,604,995 Reduced 54.81%	1,323,547 $9.78 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $481,081 - $599,313	50,962 Added 1.77%	2,928,542 $28.9 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $473,860 - $602,632	-50,898 Reduced 1.74%	2,877,580 $31.4 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $162,675 - $248,365	15,007 Added 0.52%	2,928,478 $33.1 Million
Q4 2021 Feb 11, 2022	SELL	$15.69 - $21.14 $5.07 Million - $6.83 Million	-323,053 Reduced 9.98%	2,913,471 $45.7 Million
Q3 2021 Nov 12, 2021	BUY	$15.35 - $21.27 $486,410 - $674,003	31,688 Added 0.99%	3,236,524 $55.5 Million
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $910,520 - $1.25 Million	57,958 Added 1.84%	3,204,836 $68.9 Million
Q1 2021 May 14, 2021	SELL	$13.42 - $20.28 $605,993 - $915,763	-45,156 Reduced 1.41%	3,146,878 $47.3 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $937,812 - $1.33 Million	-95,989 Reduced 2.92%	3,192,034 $41.9 Million
Q3 2020 Nov 13, 2020	SELL	$9.32 - $12.02 $23,812 - $30,711	-2,555 Reduced 0.08%	3,288,023 $31.8 Million
Q2 2020 Aug 11, 2020	BUY	$9.66 - $12.02 $865,680 - $1.08 Million	89,615 Added 2.8%	3,290,578 $37.6 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $773,557 - $1.73 Million	103,141 Added 3.33%	3,200,963 $33.2 Million
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $3.8 Million - $5.37 Million	307,226 Added 11.01%	3,097,822 $50.8 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $2.28 Million - $2.94 Million	185,904 Added 7.14%	2,790,596 $37.1 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $3.31 Million - $4.67 Million	247,850 Added 10.52%	2,604,692 $36.7 Million
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $1.78 Million - $3.15 Million	-101,442 Reduced 4.13%	2,356,842 $43.4 Million
Q4 2018 Feb 15, 2019	SELL	$18.97 - $31.47 $4.23 Million - $7.01 Million	-222,860 Reduced 8.31%	2,458,284 $64.2 Million
Q3 2018 Nov 15, 2018	BUY	$18.25 - $23.0 $2.3 Million - $2.9 Million	126,140 Added 4.94%	2,681,144 $61.5 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $3.85 Million - $5.29 Million	276,057 Added 12.11%	2,555,004 $48.7 Million
Q1 2018 May 11, 2018	BUY	$14.05 - $20.2 $144,096 - $207,171	10,256 Added 0.45%	2,278,947 $38.4 Million
Q4 2017 Feb 15, 2018	BUY	$12.85 - $18.1 $4.87 Million - $6.85 Million	378,606 Added 20.03%	2,268,691 $34.5 Million
Q3 2017 Nov 08, 2017	BUY	$15.4 - $18.85 $29.1 Million - $35.6 Million	1,890,085	1,890,085 $33.8 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$40 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.8 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.6 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$11.1 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account